Constitutive activation of NF-κB has been implicated in the pathogenesis of various cancers, such as ovarian cancer, hepatocellular carcinoma, breast cancer, lung cancer, and prostate cancer [76]. This evidence concerns the gene NFKB1 and prostate cancer.